WPSS.bio

Type

Venture Capital

Status

Active

Location

New York, United States

Total investments

17

Average round size

2M

Portfolio companies

17

Rounds per year

4.25

Exits

2

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareWellnessMedical DeviceMedicalPersonal HealthLife ScienceNeuroscienceTherapeutics

Investor highlights

Industry focus
HealthcareBiotech/Life SciencesMedtech

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
17
Lead investments
0
Exits
2
Rounds per year
4.25
Investments by industry
  • Health Care (9)
  • Biotechnology (9)
  • Medical (4)
  • Therapeutics (3)
  • Neuroscience (3)
  • Show 15 more
Investments by region
  • United States (14)
  • United Kingdom (1)
  • Germany (1)
Peak activity year
2020
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
107M
Group Appearance index
0.12
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
OpenBiome 01 Jan 2020 Biotechnology Seed United States, Massachusetts
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.